George J. Morrow
CIK: 0001068754
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- May 27, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Award(A)DirectRestriced Stock Unit
2.6K shares- - May 21, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct3.3K shares- - May 20, 2026ALGN
ALIGN TECHNOLOGY INC
Exercise(M)Direct1.7K shares- - Nov 25, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct15K shares at avg. $47.89$718K - Nov 25, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Sale(S)Direct15K shares at avg. $143.37$2.2M - May 22, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct2.9K shares- - May 21, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Award(A)DirectRestricted Stock Unit
3.3K shares- - May 21, 2025ALGN
ALIGN TECHNOLOGY INC
Exercise(M)Direct1.1K shares- - May 21, 2025ALGN
ALIGN TECHNOLOGY INC
Award(A)DirectRestricted Stock Units
1.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 27, 2026 |  NBIX NEUROCRINE BIOSCIENCES INC | Award(A) Restriced Stock Unit | 2,567 | - | - | Direct |
| May 21, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 3,318 | - | $0 | Direct |
| May 20, 2026 |  ALGN ALIGN TECHNOLOGY INC | Exercise(M) | 1,745 | - | $0 | Direct |
| Nov 25, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 15,000 | $47.89 | $718,350 | Direct |
| Nov 25, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Sale(S) | 15,000 | $143.37 | $2,150,513 | Direct |
| May 22, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 2,869 | - | - | Direct |
| May 21, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Award(A) Restricted Stock Unit | 3,318 | - | - | Direct |
| May 21, 2025 | ALGN ALIGN TECHNOLOGY INC | Exercise(M) | 1,148 | - | - | Direct |
| May 21, 2025 | ALGN ALIGN TECHNOLOGY INC | Award(A) Restricted Stock Units | 1,745 | - | - | Direct |
1-9 of 9 transactions
About MORROW GEORGE J
MORROW GEORGE J (SEC CIK 0001068754) files insider reports with the SEC as Director of NEUROCRINE BIOSCIENCES INC (NBIX) and Director of ALIGN TECHNOLOGY INC (ALGN).
Signal8 holds 6 ownership filings by MORROW GEORGE J, all Form 4s, filed between May 22, 2025 and May 29, 2026. Those filings report 9 transactions, from May 21, 2025 to May 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MORROW GEORGE J's filings is in SAN DIEGO, CA.
Recent filings by MORROW GEORGE J
- May 27, 2026: Grant or award of NBIX derivative securities (Form 4, code A).
- May 21, 2026: Option exercise of NBIX shares (Form 4, code M).
- May 20, 2026: Option exercise of ALGN shares (Form 4, code M).
- Nov 25, 2025: Option exercise of NBIX shares (Form 4, code M).
- Nov 25, 2025: Open-market sale of NBIX shares (Form 4, code S).
Other insiders filing for NEUROCRINE BIOSCIENCES INC (NBIX)
- ROBERTS EIRY, Chief Medical Officer
- Onyia Jude, Chief Scientific Officer
- Lippoldt Darin, Chief Legal Officer
- Keswani Sanjay Chandru, Chief Medical Officer
- GORMAN KEVIN CHARLES, Director
- Gano Kyle, Chief Executive Officer